Imunon to host R&D day on Phase 3 ovarian cancer trial in September

August 26, 2026 8:30 AM

Imunon, Inc. (Nasdaq: IMNN), a clinical-stage biotechnology company, announced it will host an R&D Day on September 23, 2026, at ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found